Literature DB >> 15333661

Colonic IgA producing cells and macrophages are reduced in recurrent and non-recurrent Clostridium difficile associated diarrhoea.

S S Johal1, C P Lambert, J Hammond, P D James, S P Borriello, Y R Mahida.   

Abstract

BACKGROUND: In Clostridium difficile associated diarrhoea (CDAD), histological changes in the colonic mucosa range from minimal inflammation to pseudomembranous colitis (PMC). The disease also recurs in a considerable proportion of patients. AIM: To investigate mucosal immune system cells in colonic biopsies of patients with CDAD.
METHODS: Colonic biopsies were obtained from 12 control patients with diarrhoea, six patients with CDAD and minimal inflammation, and 10 patients with CDAD with pseudomembranous colitis (samples obtained from areas with and without inflammatory exudate). Immunohistochemical studies were performed using antibodies to T cells (CD3), macrophages (CD68), B/plasma cells (CD79alpha), and to IgA, IgM, and IgG. Labelled cells in lamina propria were quantified.
RESULTS: In contrast to T cells, there were significant reductions in B/plasma cell and macrophage counts in all biopsies from patients with CDAD compared with controls (p<0.001). Studies using anti-immunoglobulin antibodies showed significant reductions in IgA producing cells in CDAD biopsies (p<0.05), with the greatest reduction in samples from patients with PMC. In contrast, there was a significant increase (p<0.05) in IgG producing cells in CDAD biopsies. Only patients with PMC relapsed. In these patients, B/plasma cell and IgA producing cell counts (in biopsies with and without inflammatory exudates) were significantly lower (p<0.01) in mucosal samples from those who subsequently relapsed (five) than those who did not.
CONCLUSIONS: A selective reduction in mucosal IgA producing cells and macrophages is associated with colonic disease in C difficile infected patients. Severe reduction in colonic IgA producing cells may predispose to recurrence of CDAD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15333661      PMCID: PMC1770426          DOI: 10.1136/jcp.2003.015875

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  38 in total

1.  Mechanism of Clostridium difficile toxin A-induced apoptosis in T84 cells.

Authors:  Gerly A C Brito; Jun Fujji; Benedito A Carneiro-Filho; Aldo A M Lima; Tom Obrig; Richard L Guerrant
Journal:  J Infect Dis       Date:  2002-10-29       Impact factor: 5.226

2.  Distribution of immunoglobulins in human rectal mucosa. II. Ulcerative colitis and abnormal mucosal control subjects.

Authors:  E A Gelzayd; S C Kraft; F W Fitch; J B Kirsner
Journal:  Gastroenterology       Date:  1968-03       Impact factor: 22.682

3.  Pseudomembranous colitis.

Authors:  A B Price; D R Davies
Journal:  J Clin Pathol       Date:  1977-01       Impact factor: 3.411

4.  Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

Authors:  L Kyne; M Warny; A Qamar; C P Kelly
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

5.  Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea.

Authors:  L Kyne; M Warny; A Qamar; C P Kelly
Journal:  Lancet       Date:  2001-01-20       Impact factor: 79.321

6.  Clostridium difficile associated diarrhoea in hospitalised patients: onset in the community and hospital and role of flexible sigmoidoscopy.

Authors:  S S Johal; J Hammond; K Solomon; P D James; Y R Mahida
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

7.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

8.  Analysis of the lympho-plasmacytic infiltrate in Crohn's disease with special reference to identification of lymphocyte-subpopulations.

Authors:  S G Meuwissen; T M Feltkamp-Vroom; A B De La Rivière; A E Von Dem Borne; G N Tytgat
Journal:  Gut       Date:  1976-10       Impact factor: 23.059

9.  Recurrent Clostridium difficile disease: epidemiology and clinical characteristics.

Authors:  L V McFarland; C M Surawicz; M Rubin; R Fekety; G W Elmer; R N Greenberg
Journal:  Infect Control Hosp Epidemiol       Date:  1999-01       Impact factor: 3.254

10.  Effect of Clostridium difficile toxin A on human colonic lamina propria cells: early loss of macrophages followed by T-cell apoptosis.

Authors:  Y R Mahida; A Galvin; S Makh; S Hyde; L Sanfilippo; S P Borriello; H F Sewell
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

View more
  25 in total

Review 1.  Intravenous immunoglobulin for the treatment of Clostridium difficile infection: a review.

Authors:  Marwan S Abougergi; John H Kwon
Journal:  Dig Dis Sci       Date:  2010-10-06       Impact factor: 3.199

Review 2.  Clostridium difficile associated diarrhoea: diagnosis and treatment.

Authors:  John Starr
Journal:  BMJ       Date:  2005-09-03

3.  Clostridioides difficile Infection Induces an Inferior IgG Response to That Induced by Immunization and Is Associated with a Lack of T Follicular Helper Cell and Memory B Cell Expansion.

Authors:  Souwelimatou Amadou Amani; Tyler Shadid; Jimmy D Ballard; Mark L Lang
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

4.  Clostridium difficile colonization in early infancy is accompanied by changes in intestinal microbiota composition.

Authors:  Clotilde Rousseau; Florence Levenez; Charlène Fouqueray; Joël Doré; Anne Collignon; Patricia Lepage
Journal:  J Clin Microbiol       Date:  2010-12-22       Impact factor: 5.948

5.  Increased expression of peripheral blood leukocyte genes implicate CD14+ tissue macrophages in cellular intestine allograft rejection.

Authors:  Chethan Ashokkumar; Mylarappa Ningappa; Sarangarajan Ranganathan; Brandon W Higgs; Qing Sun; Lori Schmitt; Sara Snyder; Jennifer Dobberstein; Maria Branca; Ronald Jaffe; Adriana Zeevi; Robert Squires; Feras Alissa; Benjamin Shneider; Kyle Soltys; Geoffrey Bond; Kareem Abu-Elmagd; Abhinav Humar; George Mazariegos; Hakon Hakonarson; Rakesh Sindhi
Journal:  Am J Pathol       Date:  2011-08-18       Impact factor: 4.307

Review 6.  Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  Nancy Fu; Titus Wong
Journal:  Curr Infect Dis Rep       Date:  2016-06       Impact factor: 3.725

Review 7.  Clostridium difficile and the microbiota.

Authors:  Anna M Seekatz; Vincent B Young
Journal:  J Clin Invest       Date:  2014-07-18       Impact factor: 14.808

8.  Essential role of toxin A in C. difficile 027 and reference strain supernatant-mediated disruption of Caco-2 intestinal epithelial barrier function.

Authors:  P A Sutton; S Li; J Webb; K Solomon; J Brazier; Y R Mahida
Journal:  Clin Exp Immunol       Date:  2008-05-26       Impact factor: 4.330

Review 9.  The host immune response to Clostridium difficile infection.

Authors:  Katie Solomon
Journal:  Ther Adv Infect Dis       Date:  2013-02

10.  Clostridium difficile infection: a critical overview.

Authors:  Bayan Missaghi; August J Valenti; Robert C Owens
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.